We deliver insights for informed decision-making and effective engagement across Payers, PBMs and patient stakeholders.

Vsh Icon Value Insights2

Value and Insights

  • Early Phase Due Diligence for Asset Acquisition
  • Evidence Value and Pricing Assessment
  • Market Shaping (PIE and PVP), Dossier and Econonomic Value Proposition
  • Payer Health Economic Models Field Tools
  • Primary and Secondary Market Research Landscape Assessments, Pipeline Asset and Portfolio Assessment
  • Payer Insights, Profiles, Strategic Councils and Ad Boards
Vsh Icon Commercial Planning2

Commercial Planning

  • Landscape Assessments
  • Market Access and Brand Marketing Strategy and Execution with Cross Functional Project Management
  • Patient Services Strategy; Hub Services Vendor RFP, Evaluation and Selection
  • Environmental Analyses and Business Planning Across Stakeholders and Sites Of Care
  • Strategic Plan Development, including Payer Engagement Planning, Quarterly Business Reviews
  • Contract Strategy and Analysis for Contract Management and Gross to Net Implications
Vsh Icon Stakeholder Engagement2

Stakeholder Engagement

  • Payer Conference Engagement Strategy and Messaging
  • Hub Services and Specialty Pharmacy Vendor Implementation and Operational Support; Patient Access Adherence
  • Market Access Field and Sales Training
  • Field Solutions and Account Management
  • Market Access KPI Monitoring, Contract Strategy Implementation and Tracking
  • Brand Omnichannel Marketing Implementation and Pull Through
About

Why Choose Us

Pharmaceutical companies now have a limited number of critical touch points with payers and patients to successfully achieve their reimbursement and product access objectives with payers/PBMs and patients.

THE VS HEALTH GROUP TEAM ARE EXPERTS IN MARKET ACCESS STRATEGY. THEY WERE AN ASSET TO HELP MITIGATE THE EFFECT OF REIMBURSEMENT CHALLENGES ACROSS OUR PORTFOLIO.

Scott Howell
NOVARTIS
Scroll to Top